Literature DB >> 19848608

CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland.

Margaret May1, Robin Wood, Landon Myer, Patrick Taffé, Andri Rauch, Manuel Battegay, Matthias Egger.   

Abstract

BACKGROUND: Estimates of the decrease in CD4(+) cell counts in untreated patients with human immunodeficiency virus (HIV) infection are important for patient care and public health. We analyzed CD4(+) cell count decreases in the Cape Town AIDS Cohort and the Swiss HIV Cohort Study.
METHODS: We used mixed-effects models and joint models that allowed for the correlation between CD4(+) cell count decreases and survival and stratified analyses by the initial cell count (50-199, 200-349, 350-499, and 500-750 cells/microL). Results are presented as the mean decrease in CD4(+) cell count with 95% confidence intervals (CIs) during the first year after the initial CD4(+) cell count.
RESULTS: A total of 784 South African (629 nonwhite) and 2030 Swiss (218 nonwhite) patients with HIV infection contributed 13,388 CD4(+) cell counts. Decreases in CD4(+) cell count were steeper in white patients, patients with higher initial CD4(+) cell counts, and older patients. Decreases ranged from a mean of 38 cells/microL (95% CI, 24-54 cells/microL) in nonwhite patients from the Swiss HIV Cohort Study 15-39 years of age with an initial CD4(+) cell count of 200-349 cells/microL to a mean of 210 cells/microL (95% CI, 143-268 cells/microL) in white patients in the Cape Town AIDS Cohort > or =40 years of age with an initial CD4(+) cell count of 500-750 cells/microL.
CONCLUSIONS: Among both patients from Switzerland and patients from South Africa, CD4(+) cell count decreases were greater in white patients with HIV infection than they were in nonwhite patients with HIV infection.

Entities:  

Mesh:

Year:  2009        PMID: 19848608      PMCID: PMC3056076          DOI: 10.1086/648096

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: results from CASCADE.

Authors: 
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

2.  Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings.

Authors:  Motasim Badri; Robin Wood
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

3.  Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania.

Authors:  Willy Urassa; Mohamed Bakari; Eric Sandström; Andrew Swai; Kisali Pallangyo; Ephraim Mbena; Fred Mhalu; Gunnel Biberfeld
Journal:  AIDS       Date:  2004-02-20       Impact factor: 4.177

4.  Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.

Authors:  Leslie R Bisset; Thomas L Lung; Matthias Kaelin; Elisabeth Ludwig; Rolf W Dubs
Journal:  Eur J Haematol       Date:  2004-03       Impact factor: 2.997

5.  Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.

Authors:  M Badri; R Ehrlich; R Wood; G Maartens
Journal:  AIDS       Date:  2001-06-15       Impact factor: 4.177

6.  Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa.

Authors:  Geoffrey S Gottlieb; Papa Salif Sow; Stephen E Hawes; Ibra Ndoye; Mary Redman; Awa M Coll-Seck; Mame A Faye-Niang; Aissatou Diop; Jane M Kuypers; Cathy W Critchlow; Richard Respess; James I Mullins; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2002-03-19       Impact factor: 5.226

7.  Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000.

Authors:  P Sudre; M Rickenbach; P Taffé; P Janin; A C Volkart; P Francioli
Journal:  Schweiz Med Wochenschr       Date:  2000-10-14

8.  Tuberculosis should not be considered an AIDS-defining illness in areas with a high tuberculosis prevalence.

Authors:  M Badri; R Ehrlich; T Pulerwitz; R Wood; G Maartens
Journal:  Int J Tuberc Lung Dis       Date:  2002-03       Impact factor: 2.373

9.  Low absolute CD4 counts in Ethiopians.

Authors:  Dawit Wolday; Aster Tsegaye; Tsehaynesh Messele
Journal:  Ethiop Med J       Date:  2002-04

10.  Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.

Authors:  Cornelia Staehelin; Martin Rickenbach; Nicola Low; Martin Egger; Bruno Ledergerber; Bernard Hirschel; Valérie D'Acremont; Manuel Battegay; Thomas Wagels; Enos Bernasconi; Christine Kopp; Hansjakob Furrer
Journal:  AIDS       Date:  2003-10-17       Impact factor: 4.177

View more
  16 in total

Review 1.  Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

Authors:  Berna C Özdemir; Gian-Paolo Dotto
Journal:  Trends Cancer       Date:  2017-03-06

2.  Factors affecting timing of antiretroviral treatment initiation based on monitoring CD4 counts.

Authors:  Farzad Noubary; Michael D Hughes
Journal:  J Acquir Immune Defic Syndr       Date:  2012-11-01       Impact factor: 3.731

3.  Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.

Authors:  Joshua T Herbeck; Viktor Müller; Brandon S Maust; Bruno Ledergerber; Carlo Torti; Simona Di Giambenedetto; Luuk Gras; Huldrych F Günthard; Lisa P Jacobson; James I Mullins; Geoffrey S Gottlieb
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

4.  Increase in CD4 count among new enrollees in HIV care in the modern antiretroviral therapy era.

Authors:  Charles F Haines; John A Fleishman; Baligh R Yehia; Stephen A Berry; Richard D Moore; Laura P Bamford; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

5.  Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.

Authors:  Thierry Buclin; Amalio Telenti; Rafael Perera; Chantal Csajka; Hansjakob Furrer; Jeffrey K Aronson; Paul P Glasziou
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

6.  Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.

Authors:  Portia C Mutevedzi; Richard J Lessells; Alison J Rodger; Marie-Louise Newell
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

7.  Semiparametric estimation of structural nested mean models with irregularly spaced longitudinal observations.

Authors:  Shu Yang
Journal:  Biometrics       Date:  2021-04-29       Impact factor: 1.701

8.  The impact of bone marrow stromal antigen-2 (BST2) gene variants on HIV-1 control in black South African individuals.

Authors:  Bianca Da Costa Dias; Maria Paximadis; Neil Martinson; Richard E Chaisson; Osman Ebrahim; Caroline T Tiemessen
Journal:  Infect Genet Evol       Date:  2020-01-30       Impact factor: 3.342

9.  The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study.

Authors:  Marina B Klein; Jim Young; David Dunn; Bruno Ledergerber; Caroline Sabin; Alessandro Cozzi-Lepri; Francois Dabis; Richard Harrigan; Darrell H Tan; Sharon Walmsley; John Gill; Curtis Cooper; Alexandra U Scherrer; Amanda Mocroft; Robert S Hogg; Fiona Smaill
Journal:  CMAJ Open       Date:  2014-10-01

10.  CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time.

Authors:  Anne Cori; Michael Pickles; Ard van Sighem; Luuk Gras; Daniela Bezemer; Peter Reiss; Christophe Fraser
Journal:  AIDS       Date:  2015-11-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.